The myocardial protective effects of esmolol or glutamate aspartate solution in open heart surgery Açik kalp cerrahisinde kardiyoplejiye eklenen esmolol veya glutamat-aspartatin miyokardiyal koruma üzerine Etkisi


KARAGÖZ A. H., Çelebioǧlu B., Duman Ü., Oǧuzalp H., Köse E. A., KANBAK M.

Turk Anesteziyoloji ve Reanimasyon Dernegi Dergisi, cilt.34, sa.5, ss.296-299, 2006 (Scopus, TRDizin) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34 Sayı: 5
  • Basım Tarihi: 2006
  • Dergi Adı: Turk Anesteziyoloji ve Reanimasyon Dernegi Dergisi
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.296-299
  • Anahtar Kelimeler: Aspartate, Esmolol, Glutamate, Myocardial protection
  • Yozgat Bozok Üniversitesi Adresli: Hayır

Özet

Background: Esmolol has been found to prevent myocardial ischemia during cardiac surgery. Furthermore, adding glutamate-aspartate to blood cardioplegia was reported as myocardio-protcetive. We aimed to compare the myocardial protective effect of esmolol and glutamate-aspartat in blood cardioplegia in elective open heart surgery. Material and Methods: Forty five adult patients, ASA grade 3 scheduled for open heart surgery were included. Patients were randomly allocated according to the agent given in bolus added to cardioplegia by an anaesthetist who was blinded to the study; Group E (csmolol), Group GA (glutamate-aspartate), Group C (control). Cardiac output (CO), cardiac index (CI), troponin T (TT) and crcatinine kinase MB (CK) were recorded after induction (t1), at the end of surgery (t2) and at 24 h postoperatively (t3). Results: Need of inotropic agent was more in Group C than the others. While values of CO in group C decreased , after the surgery values of CO was higher in Group E (p<0.05). Although there were no differences in CK among the groups in all times, after the surgery values of CK-t3 and TT-t3 increased in all patients. Values of TT-t2 were higher in Group C than other groups during the operation. Conclusion: In open heart surgery, glutamate-aspartate and esmolol given in bolus added to blood cardioplegia are an advantage in myocardial protection.